+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

Atopic Keratoconjunctivitis - Pipeline Insight, 2021 - Product Thumbnail Image

Atopic Keratoconjunctivitis - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
From
From
ST-920, Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ST-920, Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Clinical Trials - Precision and Personalized Medicine - Product Thumbnail Image

Clinical Trials - Precision and Personalized Medicine

  • Report
  • July 2023
  • 45 Pages
  • Global
From
From
From
From
Loading Indicator